Experiments with cell-free preparations of rat liver indicate that of the plant growth retardants Phosfon B, Phosfon D, B995, COlI, and Amo 1618 all but B995 inhibit at least one step between acetate and mevalonate in cholesterol biosynthesis. The results also demonstrate that all of the retardants, including B995, inhibit at least one step between mevalonate and cholesterol, and that several of them act at different points along this part of the biosynthetic sequence.
I. INTRODUCTION
Two recent articles (Paleg 1968 (Paleg , 1970 demonstrated that plant growth retardants, whose main action on plants is thought to be the inhibition of biosynthesis of gibberellins (Kende, Ninnemann, and Lang 1963; Paleg et al. 1964; Dennis, Upper, and West 1965) , also have the capability of inhibiting the biosynthesis of cholesterol. Both gibberellins and cholesterol are synthesized as products of the isoprenoid pathway which operates in plants as well as animals. The similarities of the pathways in plants and animals are further emphasized by the fact that some animal steroid inhibitors also inhibit gibberellin biosynthesis in the fungus Gibberella fujikuroi (Reid 1969) , and produce retardant-like effects on higher plants (Moore and Anderson 1966) .
In spite of the similarities in overall effect, the various retardants differ widely in dose-response relationships and in effectiveness on different species (Cathey 1964) . To explore these aspects of retardant activity, and their activities in mammalian systems, the effects of the retardants on rat liver cholesterol biosynthesis were further examined. Five retardants, Phosfon D, Phosfon S, B995, COll, and Amo 1618, were added to cell-free preparations and the redistribution of radioactivity from acetate and mevalonate in response to increasing concentrations of retardants was assessed.
II. METHODS

(a) Enzyme Preparations
Male hooded and albino Wistar rats were used in these experiments. The rats were killed by stunning after which their livers were excised, weighed, and minced coarsely in the cold. A volume of solution equal to twice the weight of the liver was added to the minced tissue and the mixture was homogenized for 30 sec in a loose-fitting, mechanically driven, glass homogenizer.
The homogenizing medium consisted of 28 mM nicotinamide, 7 mM MgCh. 6H20, and 126 mM sucrose in 44 mM KH2P04-K2HP04 buffer at pH 7· 4. After homogenization the slurry was centrifuged at 3000 r.p.m. (1400 g) for 5 min.
(b) Incubation Procedure8
Each 25 ml Ehrlenmeyer incubation flask contained 2 ml tissue supernatant, 3 ml phosphate buffer, 1 mg each of ATP, NAD, and NADPH, varying amounts of the retardant under investigation (as indicated for each table) , and a radioactive precursor. Either 10 or 20 p.Ci sodium [14C]acetate (30 mCi/mmole) or O· 5 or 1· 0 p.Ci DL-[2-14C]mevalonic acid lactone (5·03 mCi/mmole) were used as precursors. The flasks were loosely stoppered with cotton and mechanically shaken at 35°C for 3 hr.
(
c) Extraction Schedule
Addition of 2 ml 30% KOH terminated the incubation period and the mixtures were saponified at 25°C for 16 hr. Enough ethanol was added to make the reaction mixtures 50%, and the flask contents were partitioned three times with 25-ml portions of light petroleum (b.p. 60-80°C) which were combined and reduced to dryness under nitrogen. The dried residues were dissolved in 3 ml acetone-ethanol (1: 1 v Iv) and cholesterol was precipitated by adding 1·5 ml of 1 % digitonin in 55% ethanol, and a further 2·5 ml 0·4% digitonin in water 3 hr later. After a subsequent 21 hr at room temperature the solution was filtered through Whatman No.1 filter paper and the precipitate was washed once with 10 ml acetone-ether (1: 1 v Iv) and three times with 10 ml ether. The washings were added to the filtrate. The filter papers were submerged in 3 ml pyridine for 1 hr at 60°C and the solublized sterols were extracted with 60 ml light petroleum. The light petroleum was evaporated to dryness under nitrogen and the residue was taken up in a small (usually about 200 p.l) volume of chloroform-methanol (1: 1 v Iv) and spotted on thin-layer chromatography plates using Silica gel G as the adsorbant. Either hexane-diethyl ether-acetic acid (85:15:1 v/v) or ethyl acetate-hexane (1:4 v/v) was used as the solvent system and the area of the chromatogram corresponding to the cholesterol standard was scraped directly into a scintillation vial containing 10 ml Bray's (1960) mixture. Only one peak (cholesterol) was found when the chromatograms containing the digitonin-precipitable sterols were scanned for radioactivity, and 90-95% of the radioactivity in the chloroformmethanol solutions was found in the peak at the position of the cholesterol standards.
The digitonin filtrate was that portion of the original light petroleum·soluble material remaining after the digitonin-precipitable compounds were filtered off. The filtrate was reduced to dryness under nitrogen and the residue was taken up in O' 5 ml acetone-ether (1: 1 v Iv) of which an aliquot (usually 0·1 ml) was counted. All radioactivity was determined with a Packard liquid scintillation counter, model 3320.
(d) Growth Retardant8
The growth retardants used in this work and their molecular weights were Phosfon D (tributyl-2,4-dichlorobenzylphosphonium chloride, mol. wt. 398), Phosfon S (tributyl-2,4-dichlorobenzylammonium chloride, mol. wt. 381), B995 (N-dimethylaminosuccinamic acid, mol. wt. 160), COIl (N-dimethylaminomaleamic acid, mol. wt. 158), and Amo 1618 (4-hydroxy-5-isopropyl-2-methylphenyltrimethylammonium chloride, piperidine I-carboxylate, mol. wt. 354). All experiments have been repeated at least twice and the results of the replicate experiments were substantially the same as those presented below.
III. RESULTS
The effects of Phosfon D on cholesterol biosynthesis and on the radioactivity in the digitonin filtrate, with both acetate and mevalonate as precursors, are shown in Table l . Incorporation of both precursors into cholesterol was inhibited. However, at Phosfon D concentrations which caused appreciable inhibition of cholesterol biosynthesis, the digitonin filtrate slightly decreased with acetate, and increased with mevalonate. +Phosfon D (10 "g/ml) +Phosfon D (100 "g/ml) +Phosfon D (1000 "g/ml)
[14C]Mevalonate (control) +Phosfon D (10 "g/ml) +Phosfon D (100 "g/ml) +Phosfon D (1000 "g/ml) 
[14C]Acetate (control) 5,304 0·13 +Phosfon S (10 "g/ml) 4,000 0·098 24·6 +Phosfon S (100 "g/ml)
1,248 0·033 76·5 +Phosfon S (1000 "g/ml) 784 0·019 85·2
[14C]Mevalonate (control) 129,624 35·8t +Phosfon S (10 "g/ml)
123,304 34·0 +Phosfon S (100 "g/ml)
128,736 35·4 +Phosfon S (1000 "g/ml)
79,768 22·0 38·5
* Only values greater than 10% included. The effect of Phosfon S (in which the phosphonium ion of Phosfon D is replaced by a quaternary nitrogen) was compared with that of Phosfon D with mevalonate as precursor (Table 2) . Although their effects on incorporation of radioactivity into the digitonin filtrate were similar, the two compounds differed markedly in the degree of their inhibition of cholesterol biosynthesis. These results were substantiated in a comparison of the inhibitory effects of Phosfon S on acetate and mevalonate incorporation (Table 3) . Phosfon S was about as effective as Phosfon D in inhibiting cholesterol biosynthesis from acetate, but considerably less active at comparable concentrations, with mevalonate. The pattern of Phosfon S effect on radioactivity from both precursors in the digitonin filtrate was similar to that of Phosfon D.
In contrast to the effects of the two Phosfon compounds, a somewhat different effect was produced by the next two retardants, B995 and COIL No evidence of inhibition of cholesterol biosynthesis was produced by B995 with either precursor until 1000 p,g/ml was exceeded and inhibition increased rapidly above that concentration (Table 4) . At retardant concentrations which inhibited cholesterol formation, radioactivity in the digitonin filtrate decreased with both acetate and mevalonate. t Calculations based on incorporation of L-isomer only.
At lower concentrations of B995 there is an increase in incorporation into the digitonin filtrate but, at present, it is difficult to interpret this apparent stimulation.
Somewhat similar results were obtained with COll in that inhibition of both acetate and mevalonate incorporation into cholesterol was essentially absent or at least very slight until a concentration of 1000 p,g/ml was exceeded (Table 5) on radioactivity in the digitonin filtrate when mevalonate was the precursor, but radioactivity from acetate in this fraction decreased at the highest COlI concentration. Table 6 illustrates the results obtained from similar experiments with Amo 1618. Inhibition of both acetate and mevalonate incorporation into cholesterol is evident. When acetate was the precursor, only a slight decrease in the radioactivity in the digitonin filtrate was observed. However, with mevalonate, marked increases in the filtrate radioactivity were produced by increasing concentrations of the retardant. Other experiments indicated that Amo 1618 consistently caused inhibition of cholesterol biosynthesis at 10 p,g/ml, and, on occasion, it has even been slightly·inhibitory at 1 p,g/ml. Several other compounds were also tested in this system. Maleic hydrazide was added at concentrations of 10, 100, and 1?00 p,g/ml with both acetate and mevalonate and was found not to inhibit the synthesis of cholesterol. In addition, another quaternary nitrogen-containing compound, tris(hydroxymethyl)aminomethane, was tested at 10, 100, and 1000 fl-gfml with both precursors and was also found to be non-inhibitory. Lastly, the animal steroid biosynthesis inhibitor SK&F 7997 (which also contains a quaternary nitrogen) was tested with acetate as precursor. The similarity of this system to that used by others is indicated by the fact that incorporation of acetate (Table 7) , like mevalonate (Holmes and Bentz 1960; Holmes and Di Tullio 1962) , is inhibited by increasing concentrations of the inhibitor. The major biosynthetic path by which cholesterol is formed may be divided into two parts on the basis of the solubility characteristics of the intermediates. Components up to and including farnesyl pyrophosphate are not or are only very poorly extracted from aqueous solution by organic solvents. On the other hand, the lipophilic nature of most of the intermediates formed after farnesyl pyrophosphate (e.g. squalene, lanosterol, cholesterol, etc.), causes their ready partitioning into lipophilic organic solvents. In these experiments the incubation mixture following saponification was extracted with light petroleum and, presumably, the bulk of only those intermediates which were formed subsequent to farnesyl pyrophosphate were extracted. This fraction (the light petroleum-soluble compounds) was then exposed to digitonin which complexes with sterols of specific configurations (Fieser and Fieser 1950) , and the radioactivity remaining after filtering off the digitonin precipitate has been assumed to be associated with the intermediates formed subsequent to farnesyl pyrophosphate. Thus, if any step in the conversion of squalene to cholesterol is inhibited, radioactivity in the digitonin filtrate will decrease. It must be understood, however, that these general relationships may not always be completely accurate since, for example, pyrophosphatase activity can convert any of the phosphorylated intermediates into light petroleum-soluble alcohols which would also appear in the digitonin filtrate. [A situation similar to this was noted by Dennis, Upper, and West (1965) in their investigation of the effect of Amo 1618 on kaurene biosynthesis by Echinocystis endosperm preparations. They found trans-geranylgeraniol accumulating and deduced that it was formed from transgeranylgeranyl pyrophosphate.] However, regardless of the precise reason for the pattern of distribution of radioactivity caused by a growth retardant (i.e. whether radioactivity is in a cholesterol precursor or in a metabolic by-product of a precursor) the same pattern should be obtained with both acetate and mevalonate as precursors, if the retardant has only one point of effect which is subsequent to mevalonate. On the other hand, if the pattern of change in radioactivity in the fractions is different with acetate from what it is with mevalonate, and cholesterol synthesis is inhibited with both, the conclusion seems inescapable that the retardant is affecting the incorporation of the two precursors in different ways and, consequently, must have more than one site of action. In the present report, no attempt was made to identify intermediates or specific sites of inhibition, and attention has been devoted solely to effects on patterns in distribution of radioactivity in both the digitonin-precipitable fraction / (cholesterol) and the digitonin filtrate.
The data presented here support the previous conclusions (Paleg 1968 (Paleg , 1970 ) that all of the retardants inhibit the incorporation of both [14C]acetate and [14C]mevalonate into cholesterol. Although the earlier work left open the possibility that the retardants all acted at the same steps in the biosynthetic sequence, these results provide evidence that each of the retardants (with the possible exception of B995), in fact, inhibits the pathway at more than one step. Since B995, at concentrations which inhibit cholesterol biosynthesis, has the same effect on acetate as on mevalonate incorporation, it is not yet possible to conclude that B995 does, in fact, inhibit a step between acetate and mevalonate. The effects of the other retardants on the redistribution of radioactivity derived from [14C]acetate, although somewhat variable, appear to be similar in that, at concentrations which inhibit cholesterol synthesis, they cause a decrease in radioactivity in the digitonin filtrate. Previous work (Gould and Swyryd 1966) has implicated the conversion of ,8-hydroxy-,8-methyl glutaryl CoA to mevalonate as a particularly inhibitor-sensitive step, and some of the compounds tested in this work may also be acting at that point. When mevalonate was employed, however, the retardant-induced distribution of radioactivity exhibits distinctive features, as summarized in the following tabulation: This strongly suggests that most of the retardants are acting at steps which are different from each other and from the block evident with acetate. At concentrations which inhibit cholesterol formation, Phosfon D, Phosfon S, COll, and Amo 1618 caused increases in the radioactivity in the digitonin filtrate, whereas B995 caused a slight increase and then a decrease. The retardants were further compared by plotting the increases in digitonin filtrate radioactivity against their inhibition of cholesterol biosynthesis when mevalonate was the precursor (Fig. 1) . Amo 1618 clearly produced an effect, evident both in rate of increase and total amount of increase in filtrate activity, that was different from the other retardants. Phosfon S and Phosfon D both caused moderate increases in accumulation of radioactivity in the digitonin filtrate, and the levels attained at any particular level of inhibition of cholesterol were appreciably less than Amo 1618 but considerably more than B995 or COlI or both. Thus, with respect to effects on the incorporation of mevalonate, these retardants appear to form three recognizable groups, the first comprising AIDo 1618, the second the Phosfon derivatives, and the third containing the succinamic acids, B995 and COIL It seems likely that these groups differ either in their points of inhibition of the isoprenoid pathway, or in the nature of their inhibiting effect. The comparative effects of Phosfon Sand Phosfon D also suggest that they may differ in the precise point of inhibition, but further work is required to clarify this point. B995 and COlI have similar concentration thresholds in terms of their inhibition of cholesterol formation, with both precursors, though their effects at these concentrations on the distribution of radioactivity from mevalonate in the digitonin filtrate seem to differ slightly. If, as suggested by Dahlgren and Simmerman (1963) and Reed, Moore, and Anderson (1965) , the decomposition product of COlI is the active moiety and B995 is also active through a comparable though much less complete degradation, it is difficult to understand why the retardants manifest similar dose-response relationships in this work with respect to inhibition of cholesterol biosynthesis.
The ineffectiveness of maleic hydrazide at concentrations up to 1000 ""g!ml is of interest. Since maleic hydrazide is so similar in structure to B995 and COIl (Paleg et al. 1964) , it might be expected that higher concentrations of the hydrazide would also inhibit cholesterol biosynthesis. However, maleic hydrazide usually affects plant growth at concentrations considerably less than 1000 ""g!ml whereas concentrations of B995 and COIl higher than 1000 ""g!ml are usually required for physiological effectiveness. This suggests that inhibition of the isoprenoid biosynthetic pathway is not a capacity shared uniformly by all physiologically active compounds. This conclusion is supported by the lack of effect of tris(hydroxymethyl)-aminomethane which, like Amo 1618, Phosfon S, and SK&F 7997, is a physiologically active quaternary nitrogen-containing compound (Furness 1961) .
In plants, many, but not all, of the physiological effects of the retardants can be reversed by application of the diterpenoid plant hormone gibberellic acid. However, since squalene, cholesterol, and many other sterols are common constituents of plants and may be important components of membranes, it seems very likely that the inhibition of sterol biosynthesis in plants, as well as inhibition of diterpene biosynthesis, may also be an important aspect of retardant action. In addition, since several of the retardants inhibit at different steps along the common isoprenoid pathway, some of the individual retardant effects may be due to the differential metabolism of the compounds accumulated as a result of the block. Finally, because the retardants comprise a group of heterogeneous chemical structures, it can be expected that they will also (1) differ in the ease with which they reach the location of the susceptible enzymes, (2) differ in their susceptibility to biological decomposition or inactivation or both, and (3) exhibit unique and unrelated physiological effects.
The specificity and individuality of these compounds and the nature of their effects make them an important and interesting group of chemicals for both plant and animal physiologists. It seems likely that an understanding of their precise effects will enhance our knowledge of, and control over, essential areas of metabolism.
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